Sugi Predict

Sugi Predict / Targets / SNRPB2

SNRPB2

U2 small nuclear ribonucleoprotein B'' · P08579 · SNRPB2 on Sugi Atlas →

0 patent compounds predicted against SNRPB2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SNRPB2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study nanUNKNOWN
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Timisnar - Biomarkers Substudy (Timisnar-mirna) nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SNRPB2 binder may also engage these)

ProteinNameSimilarity
Q9CQI7 — 0.996 Q9CQI7 →
P43332 — 0.973 P43332 →
Q06AA4 — 0.960 Q06AA4 →
O22922 — 0.959 O22922 →
SNRPA U1 small nuclear ribonucleoprotein A 0.958 landscape →
Q2KIR1 — 0.957 Q2KIR1 →
Q8H1S6 — 0.952 Q8H1S6 →
Q62189 — 0.947 Q62189 →
P45429 — 0.939 P45429 →
Q9MAC5 — 0.934 Q9MAC5 →
HNRNPLL Heterogeneous nuclear ribonucleoprotein L-like 0.931 landscape →
Q9FGL9 — 0.931 Q9FGL9 →
Q8R081 — 0.923 Q8R081 →
A2Y0J7 — 0.920 A2Y0J7 →
Q0DKM4 — 0.920 Q0DKM4 →
HNRNPL Heterogeneous nuclear ribonucleoprotein L 0.916 landscape →
F1LQ48 — 0.914 F1LQ48 →
Q66HR2 — 0.913 Q66HR2 →
Q863I2 — 0.911 Q863I2 →
MAPKAPK2 MAP kinase-activated protein kinase 2 0.911 landscape →
Q921F4 — 0.911 Q921F4 →
O55029 — 0.910 O55029 →
B8AM21 — 0.910 B8AM21 →
Q5ZKU1 — 0.910 Q5ZKU1 →
Q61166 — 0.909 Q61166 →
Q3ZBD9 — 0.909 Q3ZBD9 →
Q5R7Z5 — 0.909 Q5R7Z5 →
Q5PYH5 — 0.909 Q5PYH5 →
STK39 STE20/SPS1-related proline-alanine-rich protein kinase 0.908 landscape →
MAPRE1 Microtubule-associated protein RP/EB family member 1 0.908 landscape →